Earnings Call Summary | Materialise(MTLS.US) Q2 2024 Earnings Conference
Earnings Call Summary | Materialise(MTLS.US) Q2 2024 Earnings Conference
Adjusted EBIT for Q2 2024 was €3.9 million, up from -€0.6 million in Q2 2023, demonstrating significant improvement.The following is a summary of the Materialise NV (MTLS) Q2 2024 Earnings Call Transcript:
以下是Materialise NV（MTLS）2024年第二季度業績會交流總結：
Financial Performance:
金融業績：
Materialise NV reported a Q2 2024 revenue of €68.8 million, a 6% increase year-over-year.
Gross margin remains strong at 57%, consistent with Q2 2023 levels.
Adjusted EBIT for Q2 2024 was €3.9 million, up from -€0.6 million in Q2 2023, demonstrating significant improvement.
Net profit reached €3.9 million, or €0.07 per share.
Materialise NV報告2024年第二季度營業收入爲6880萬歐元，同比增長6%。
毛利率維持在57%，與2023年第二季度水平持平。
2024年第二季度調整後EBIT爲390萬歐元，較2023年第二季度的-60萬歐元增長，表現出顯著的改善。
淨利潤達到390萬歐元，每股0.07歐元。
Business Progress:
業務進展：
Acquired FEops, specializing in AI-driven simulation technology for structural heart interventions, enhancing their medical segment.
Launched Mimics Planner for Structural Heart Interventions in 2019, which utilizes 3D modeling and design.
Initiated a partnership with nTop to address challenges of complex 3D printing files through Materialise's Magics and Next-Generation Build Processor.
Actively encouraging collaboration across the 3D printing industry to remove adoption barriers.
收購FEops，專注於結構性心臟手術AI驅動模擬技術，增強其醫療板塊。
於2019年推出Mimics Planner，用於結構性心臟操作，利用3D建模和設計。
與nTop合作，通過Materialise的Magics和下一代建造處理器解決複雜3D打印文件的挑戰。
積極鼓勵3D打印行業合作，消除採用障礙。
Opportunities:
機會：
Expansion into new market segments through strategic acquisitions like FEops and partnerships with companies like nTop.
Enhancement of Materialise's software capabilities and integration with advanced 3D printing technologies to process complex designs more efficiently, supporting the growth of end-use parts manufacturing in various industries.
通過戰略收購（如FEops）和與像nTop這樣的公司合作，擴展到新的市場領域。
加強Materialise的軟件能力，並與先進的3D打印技術集成，以更高效地處理複雜設計，支持各行業終端零部件製造的增長。
Risks:
風險：
Acknowledged structural weaknesses in the prototyping market, projected to persist, affecting the manufacturing segment.
Financial impact from FEops integration, with expected initial negative impacts on EBIT as investments continue.
承認原型製造市場存在結構性弱點，預計將持續影響製造板塊。
來自FEops整合的財務影響，預期最初將對EBIT產生負面影響，因爲投資還在繼續。
More details: Materialise IR
更多詳情：Materialise IR
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：如需更全面的詳情，請參閱投資人關係網站。本文僅供投資者參考，不作任何指引或建議。
譯文內容由第三人軟體翻譯。
